4.3 Article

Variation and expression of HLA-DPB1 gene in HBV infection

Journal

IMMUNOGENETICS
Volume 73, Issue 3, Pages 253-261

Publisher

SPRINGER
DOI: 10.1007/s00251-021-01213-w

Keywords

HLA-DPB1 gene; Gene expression; Hepatitis B virus; Infection susceptibility; Spontaneous virus clearance; Disease progression

Funding

  1. CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-3-024]
  2. Sichuan Science and Technology Department [2017RZ0047, 2018SZ0395]
  3. Ministry of Science and Technology of China [2014EG150133]

Ask authors/readers for more resources

HLA-DPB1 gene polymorphisms and rs9277535 polymorphisms are associated with HBV infection, with certain genotypes providing protection against or increased susceptibility to HBV infection. Different alleles have varying effects on HBV susceptibility and spontaneous clearance.
Hepatitis B virus (HBV) affects approximately 68 million people in China, and 10-15% of adults infected with HBV develop chronic hepatitis B, liver cirrhosis, liver failure or hepatocellular carcinoma (HCC). HLA-DPB1 gene polymorphism and expression have been shown to be associated with HBV infection susceptibility and spontaneous clearance. The aim of this study is to evaluate the role of HLA-DPB1 gene polymorphism in HBV infection. HLA-DPB1 and rs9277535 polymorphisms were investigated in 259 patients with HBV infection and 442 healthy controls (HCs) using sequence-based typing. The mRNA of HLA-DPB1 was measured by real-time polymerase chain reaction. HLA-DPB1 genes and rs9277535 polymorphisms were all associated with HBV infection in the Sichuan Han population. rs9277535A and HLA-DPB1*04:02 played a protective role against HBV infection. rs9277535G and DPB1*05:01 were associated with susceptibility to HBV infection. rs9277535GG had significantly higher HLA-DPB1 mRNA expression in the HBV infection group compared with the HC group. HLA-DPB1*05:01 and HLA-DPB1*21:01 had significantly lower mRNA expression in the HBV infection group compared with the HC group. The meta-analysis revealed that HLA-DPB1*02:01, HLA-DPB1*02:02, HAL-DPB1*04:01 and HLA-DPB1*04:02 protected against HBV infection, while HLA-DPB1*05:01, HLA-DPB1*09:01, and HLA-DPB1*13:01 were risk factors for susceptibility to HBV infection. HLA-DPB1*02:01, HLA-DPB1*02:02, and HLA-DPB1*04:01 were associated with HBV spontaneous clearance, while HLA-DPB1*05:01 was associated with chronic HBV infection. HLA-DPB1 alleles and rs9277535 have a major effect on the risk of HBV infection, and HBV infection is associated with lower HLA-DPB1 expression. HLA-DPB1 alleles have an important role in HBV susceptibility and spontaneous clearance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, General & Internal

Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial

Ling Li, Wei Zhang, Yu Hu, Xunliang Tong, Shangen Zheng, Juntao Yang, Yujie Kong, Lili Ren, Qing Wei, Heng Mei, Caiying Hu, Cuihua Tao, Ru Yang, Jue Wang, Yongpei Yu, Yong Guo, Xiaoxiong Wu, Zhihua Xu, Li Zeng, Nian Xiong, Lifeng Chen, Juan Wang, Ning Man, Yu Liu, Haixia Xu, E. Deng, Xuejun Zhang, Chenyue Li, Conghui Wang, Shisheng Su, Linqi Zhang, Jianwei Wang, Yanyun Wu, Zhong Liu

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Urology & Nephrology

Identical twins with idiopathic membranous nephropathy

Tian Tao, Jue Wang, Song Lei, Zhangxue Hu

Summary: The pathogenesis of idiopathic membranous nephropathy involves autoantibodies and genetic factors, particularly HLA genes. Rare cases of idiopathic membranous nephropathy in twins provide valuable insights into the genetic and molecular mechanisms of the disease.

JOURNAL OF NEPHROLOGY (2021)

Article Medicine, Research & Experimental

Analysis of viral load in different specimen types and serum antibody levels of COVID-19 patients

Ling Li, Chianru Tan, Jia Zeng, Chen Luo, Shi Hu, Yanke Peng, Wenjuan Li, Zhixiong Xie, Yueming Ling, Xuejun Zhang, E. Deng, Haixia Xu, Jue Wang, Yudi Xie, Yaling Zhou, Wei Zhang, Yong Guo, Zhong Liu

Summary: This study collected nasopharyngeal swabs, anal swabs, saliva, blood, and urine specimens from patients with a course of disease ranging from 7 to 69 days. It was found that the positive detection rate was highest in nasopharyngeal swabs, followed by anal swabs. There was no significant correlation between antibody levels and days after symptom onset or viral load.

JOURNAL OF TRANSLATIONAL MEDICINE (2021)

Article Hematology

First annual report of Chinese haemovigilance network

Yonghua Yin, Xue Tian, Ling Li, Yujie Kong, Jue Wang, Feng Lin, Ning Song, Qiang Chen, Jia Gan, Tao Peng, Xiying Li, Yanyun Wu, Hongwei Ge, Hongjie Wang, Jingmei Jiang, Lianjun Bai, Hongwen Ji, Guohua Zhao, Yuguang Huang, Zhong Liu

Summary: This report provides the first comprehensive overview of transfusion-related adverse reactions in China, highlighting that allergic reactions and FNHTR are the most common adverse symptoms. Most adverse reactions resulted in hospitalization or prolongation of hospitalization for patients, with the ratio of serious adverse reactions being 8.2%.

VOX SANGUINIS (2021)

Article Hematology

Donor tolerability of convalescent plasma donation

Rui He, Hui Lin, Songli Xie, Qilu Lv, Yujie Kong, Ling Li, Haixia Xu, Jue Wang, Wenjuan Li, Peng Fang, Yanyun Wu, Zhong Liu

Summary: This study evaluated the short-term donor tolerability of convalescent plasma donation and found that all adverse events were mild vasovagal without relation to factors like weight, sex, or blood type. Overall, the donation of convalescent plasma is safe, but mitigation of risk factors associated with adverse events can further enhance donor tolerability.

JOURNAL OF CLINICAL APHERESIS (2021)

Article Hematology

A possible dose-response equation: Viral load after plasma infusion in COVID-19 patients and anti-SARS-CoV-2 antibody titers in convalescent plasma

Rui He, Jue Wang, Zhenmeng Wang, Yu Liu, Haixia Xu, Xuejun Zhang, E. Deng, Yundi Yin, Xin Ji, Xiaoyu Guan, Qi Ren, Caixia Wu, Yongjun Chen, Ling Li, Wei Zhang, Zhong Liu

Summary: This study proposed a potential estimation equation for evaluating the dose of high antibody titer convalescent plasma, which could assist in the rational allocation of plasma with high antibody titers and provide an individualized treatment strategy for convalescent plasma therapy.

TRANSFUSION MEDICINE (2022)

Article Hematology

Development of the Chinese Haemovigilance Network and reporting of adverse transfusion reactions from 2018 to 2020

Xue Tian, Yujie Kong, Jue Wang, Rui He, Ling Li, Zhong Liu

Summary: This report describes the development of the Chinese Haemovigilance Network (CHN) and evaluates its role in advancing blood transfusion safety by analyzing reported adverse transfusion reactions (ATRs) from 2018 to 2020. The study found that the establishment of CHN has increased ATR recognition and management, although under-reporting of ATRs still occurs in many Chinese hospitals.

VOX SANGUINIS (2022)

Editorial Material Cell Biology

Detection of a novel HLA-B allele, HLA-B48:54 in a Chinese individual

Xin Ji, Chen Luo, Jue Wang, Qiang Chen, Liu Zhong

Summary: A novel HLA-B*48:54 allele was discovered in an individual from China's Sichuan province.
Editorial Material Cell Biology

Identification of a novel HLA-C08 allele, HLA-C08:242 in a Chinese individual

Chen Luo, Xin Ji, Zhong Liu, Qiang Chen, Jue Wang

Summary: The novel HLA-C*08:242 allele was identified in an individual from the Sichuan province of China.
Editorial Material Cell Biology

Description of the novel HLA-A allele, HLA-A*02:937 in a Chinese individual

ZhiHang He, Xin Ji, Chen Luo, Qiang Chen, Jue Wang

Summary: The sentence describes a nucleotide change at codon 182 of exon 3 (ACG>GCG) between HLA-A*02:937 and HLA-A*02:07:01:01.
Article Immunology

Neutralization effect of plasma from vaccinated COVID-19 convalescents on SARS-CoV-2 Omicron variants

Yudi Xie, Lei Liu, Jue Wang, Yaqiong Zheng, Chen Luo, Wenxu Ni, Zhihang He, Xin Zhao, Yan Liu, Yingyu He, Shangen Zheng, Ling Li, Zhong Liu

Summary: Among the 64 plasma samples of COVID-19 convalescents, whether vaccinated or not, Omicron (B.1.1.529) escaped the neutralizing antibodies, with a significantly decreased neutralization activity compared to WT. And two-dose of the vaccine could significantly raise the average neutralization of Omicron in convalescent individuals.

FRONTIERS IN IMMUNOLOGY (2022)

Article Hematology

Investigating the Correlation Between HLA-II Gene Polymorphism and RhE Alloimmunization in Pregnant Chinese Women

Wenling Shang, Guojin Ou, Xin Ji, Jian Chen, Jue Wang, Yongmei Jiang

Summary: The study aimed to verify the correlation between HLA-II gene polymorphisms and RhE alloimmunization in pregnant Chinese women through HLA-II typing and DR-RhE structural prediction. The results showed a significant positive association between the HLA-DRB1*09:01-DQA1*03:02-DQB1*03:03 haplotype and anti-E. One E-derived anchoring peptide (219FWPSVNSPL227) was predicted to bind to the HLA-DRB1*09:01 molecule. This study demonstrated that HLA-II haplotypes are associated with allo-anti-E antibodies in pregnant women from Sichuan Province, China.

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2023)

Article Medical Laboratory Technology

Transfusion-Related Acute Lung Injury Caused by HLA-II Antibodies: A Case Report

Xinxin Hao, Jue Wang, Tiegang Li, Qiushi Wang

Summary: This study retrospectively analyzed the etiology of a suspected case of transfusion-related acute lung injury (TRALI) after blood transfusion, and found that the patient's condition was related to HLA genes and HLA antibodies.

LABORATORY MEDICINE (2023)

Article Cell Biology

Frequency and molecular basis of CD36 deficiency among platelet donors in Kunming, China

Qilu Lyu, Mozhen Peng, Qiang Chen, Xin Ji, Zhijiang Wang, Qian Li, Zhihui Zhang, Zhen Luo, Yonghua Yin, Pincan Su, Sentot Santoso, Jue Wang

Summary: This study identified the incidence of CD36 deficiency among platelet donors in Kunming and investigated the molecular basis of this deficiency. It was found that 1.68% of the donors had CD36 deficiency, with 0.24% having type I deficiency and 1.44% having type II deficiency. Heterozygous mutations were detected in these individuals, which may contribute to the CD36 deficiency.

PLATELETS (2023)

No Data Available